68

Maider Medical Industry Equipment Co Ltd

688310 · SHG · Healthcare / Medical Instruments & Supplies

11.92CNY-0.30 (-2.45%)

Price History

Full chart

Market Stats

Previous Close12.22
Open12.25
Day Range11.82 – 12.38
52-Week Range11.66 – 21.38
Volume1.13M
Market Cap2.50B
P/E (TTM)58.54
Forward P/E0.00
EPS0.26
Dividend Yield1.64%
Beta0.69
50-Day Avg14.70
200-Day Avg15.98

About

Maider Medical Industry Equipment Co. Ltd. engages in the research, development, production, sale, and service of intelligent equipment for medical consumables in China and internationally. The company offers Safety infusion equipment, such as self-destructing safety and insulin syringes; safety injection, indwelling, insulin, blood collection, and mini safety blood collection needles; central venous catheters; and infusion sets. It also offers blood purification solutions, including automatic assembly machine for hemodialyzer, AV fistula needle, hemoperfusion cartridge, flushing syringe, dialysis bloodline, peritoneal dialysis, and powder barrel; automatic spinning machine for hollow fiber membrane; and infusion solution, such as automatic assembly machine for IV catheters and sets, and enteral feeding set. In addition, the company offers automatic assembly machine for aesthetic injection needle, pre-filled syringe, disposable transfusion sets, blood transfusion bag, leukocyte filter, membrane oxygenator, suction catheter, inhaler, nasal cannula, biopsy needle, urinary catheter and bags, vacuum blood collection, disposable pump extension tubing, disposable spinal anesthesia needles, insulin pen needle and syringe, CGM components, immunology and biochemical reagents, vial, and cartridge. Further, it offers packaging solutions, including automatic packaging solution for cartoning and case packing, cable ties, bagged products, and blister packaging. Additionally, the company engages in wholesale activity. Maider Medical Industry Equipment Co. Ltd. was founded in 2003 and is headquartered in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Junhua Lin
  • Employees781
  • HeadquartersNo.5 Jubao Road, Taizhou, China, 317607, China
  • Websitehttps://www.maiderchina.com

Leadership

  • Mr. Junhua LinChairman of the Board & GM · b. 1978
  • Mr. Junhui LinCFO & Director · b. 1980
  • Mr. Dong LinDeputy GM, Director & Board Secretary · b. 1990

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue130.95M141.35M144.72M139.43M173.39M214.90M209.55M263.17M315.53M383.49M480.22M274.85M447.42M
Growth (%)-+7.94%+2.38%-3.65%+24.36%+23.94%-2.49%+25.59%+19.90%+21.54%+25.22%-42.77%+62.79%
Cost of Revenue70.41M73.41M73.38M68.13M82.99M110.40M107.85M131.45M159.32M191.43M235.72M156.93M247.58M
Gross Profit60.53M67.94M71.34M71.30M90.40M104.50M101.70M131.72M156.21M192.06M244.50M117.92M447.42M
Gross Margin46.23%48.07%49.30%51.13%52.14%48.63%48.53%50.05%49.51%50.08%50.91%42.90%100.00%
Operating Expense35.06M43.92M46.59M54.02M27.56M40.10M50.77M63.42M88.42M105.14M116.53M145.32M387.72M
Operating Income25.48M24.02M24.75M17.27M62.84M64.40M50.93M68.30M67.79M86.92M127.97M-27.40M59.70M
Operating Margin19.46%16.99%17.10%12.39%36.24%29.97%24.30%25.95%21.48%22.66%26.65%-9.97%13.34%
EBITDA373.95M37.32M45.59M36.17M72.23M70.53M61.11M74.95M77.13M102.35M156.01M1.63M92.02M
EBITDA Margin285.57%26.41%31.51%25.94%41.66%32.82%29.16%28.48%24.44%26.69%32.49%0.59%20.57%
Net Income23.45M24.51M32.19M23.40M55.84M56.01M46.75M59.07M64.48M67.02M99.83M-19.98M65.26M
Net Income Margin17.91%17.34%22.24%16.78%32.21%26.06%22.31%22.45%20.44%17.48%20.79%-7.27%14.59%
R&D9.75M11.95M12.67M13.70M13.82M19.42M20.57M26.23M38.46M36.66M33.18M40.41M47.20M
R&D as % of Total Revenue7.45%8.45%8.75%9.82%7.97%9.04%9.82%9.97%12.19%9.56%6.91%14.70%10.55%
Interest Expense538.30K885.48K1.39M1.19M050.63K1.14M146.41K186.31K159.32K154.23K64.13K1.60M
Interest Expense % of Total Revenue0.41%0.63%0.96%0.85%0.00%0.02%0.54%0.06%0.06%0.04%0.03%0.02%0.36%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets199.44M217.78M211.37M229.64M283.33M328.93M804.42M816.01M879.31M1.04B1.15B1.05B1.19B
Total Liabilities105.27M99.10M60.50M56.97M54.63M75.45M97.48M80.29M116.67M208.66M209.60M207.96M310.41M
Total Equity94.17M118.68M150.87M172.67M228.70M253.35M707.27M736.96M764.36M819.18M893.84M810.05M862.08M
Cash4.43M5.63M4.82M19.38M65.20M68.93M112.95M425.46M314.84M224.95M289.02M118.22M234.42M
Total Debt10.00M33.00M23.00M11.00M1.35M-25.83M1.75M2.72M1.37M1.77M43.14M-
Net Debt5.57M27.37M18.18M-8.38M-63.85M-68.93M-87.12M-423.71M-312.13M-223.58M-287.25M-88.03M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.02M-11.28M4.07M40.31M72.02M31.14M14.14M70.09M84.89M97.34M110.91M56.56M151.22M
Investing Cash Flow-1.97M-8.31M6.51M-3.16M-13.43M5.83M-402.50M301.85M-152.16M-159.97M-32.42M-174.70M-
Financing Cash Flow-10.56M22.23M-11.40M-23.99M-12.67M-31.37M431.16M-58.09M-43.01M-30.87M-8.30M-39.51M-
Capital Expenditure20.03M4.16M3.67M3.34M2.93M5.76M31.72M66.18M112.65M135.70M72.21M86.02M53.95M
Free Cash Flow-8.01M-15.44M401.15K36.98M69.09M25.38M-17.59M3.91M-27.77M-38.36M38.70M-29.46M97.26M
Dividends Paid558.76K765.24K1.40M52.11M288.33K31.35M50.16M29.44M41.80M31.77M40.27M59.02M1.27M
FCF to OCF-66.70%136.87%9.85%91.73%95.93%81.51%-124.41%5.58%-32.71%-39.41%34.89%-52.08%64.32%
Dividend Paid to FCF-6.97%-4.96%350.13%140.94%0.42%123.50%-285.24%752.54%-150.55%-82.81%104.06%-200.37%1.30%

Earnings

Report DateNov 12, 2019Dec 31, 2019Apr 24, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate0.00--------------
EPS Actual0.010.260.480.310.090.060.080.120.130.220.020.070.070.410.11
Surprise---------------
Timing---------------

Key Statistics & Ratios

Market Cap2.50B
Enterprise Value2.44B
Trailing P/E58.54
Forward P/E0.00
Price / Sales5.36
Price / Book3.39
EPS0.26
Book Value4.80
Revenue (TTM)466.34M
Gross Profit (TTM)199.88M
EBITDA49.40M
Profit Margin9.12%
Operating Margin-12.35%
Return on Equity1.56%
Return on Assets0.57%
Shares Outstanding164.32M
Shares Float48.34M
Beta0.69
Dividend Yield1.64%
Dividend Rate0.25
Payout Ratio96.15%

Dividends

20261×
0.25Jun 18, 2026
20241×
0.50Jun 12, 2024
20231×
0.34Jun 9, 2023
20221×
0.19Jun 6, 2022
20211×
0.26May 25, 2021
20201×
0.18Jun 16, 2020

Stock Splits

  • Jun 12, 20241.4:1
  • Jun 9, 20231.4:1